Free Trial
→ SpaceX is offering you shares. Don't take them. (From Behind the Markets) (Ad)tc pixel Free CIM Stock Alerts

Chimera Investment (CIM) Financials

Chimera Investment logo
$13.53 +0.15 (+1.12%)
Closing price 03:59 PM Eastern
Extended Trading
$13.46 -0.06 (-0.48%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Chimera Investment

Annual Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 250 549 491 368 341 15 596 -587 52 90 144
Consolidated Net Income / (Loss)		 250 552 525 412 414 89 670 -513 126 176 230
Net Income / (Loss) Continuing Operations		 250 552 525 412 414 89 670 -513 126 176 230
Total Pre-Tax Income 		250 552 525 412 414 89 675 -513 126 176 233
Total Revenue		 344 645 697 542 541 212 810 -380 241 288 387
Net Interest Income / (Expense)		 613 586 606 594 602 514 611 440 263 265 266
Total Interest Income		 873 934 1,139 1,273 1,361 1,030 938 773 773 761 821
Investment Securities Interest Income		 873 934 1,139 1,273 1,361 1,030 938 773 773 761 821
Total Interest Expense		 259 348 533 679 759 516 327 333 510 496 555
Long-Term Debt Interest Expense		 259 - 533 679 759 516 327 333 510 496 555
Total Non-Interest Income		 -270 59 91 -53 -61 -302 199 -820 -22 23 120
Net Realized & Unrealized Capital Gains on Investments		 -270 -27 91 -53 -61 -302 199 -820 -22 20 84
Investment Banking Income		 - - - - - - - 0.00 0.00 2.71 35
Other Non-Interest Income		 - -9.59 - - - - - - 0.00 0.00 0.52
Provision for Credit Losses		 - - - 0.00 0.00 - 0.03 7.04 11 9.84 16
Total Non-Interest Expense		 93 93 173 130 128 123 135 126 104 102 138
Salaries and Employee Benefits		 11 27 30 35 49 45 47 49 31 41 57
Other Operating Expenses		 83 66 81 73 74 78 89 77 73 60 74
Depreciation Expense		 - - - - - - - 0.00 0.00 0.32 7.18
Income Tax Expense		 0.00 0.08 0.00 0.09 0.19 0.16 4.41 -0.25 0.10 0.05 2.27
Preferred Stock Dividends Declared		 0.00 2.45 33 43 73 74 74 74 74 86 86
Basic Earnings per Share		 $1.25 $2.93 $2.62 $1.97 $1.82 $0.07 $2.55 ($7.53) $0.68 $1.12 $1.76
Weighted Average Basic Shares Outstanding		 199.56M 187.73M 187.78M 187.15M 187.16M 213.00M 233.77M 77.98M 76.69M 80.98M 82.18M
Diluted Earnings per Share		 $1.25 $2.92 $2.61 $1.96 $1.81 $0.07 $2.44 ($7.53) $0.68 $1.10 $1.72
Weighted Average Diluted Shares Outstanding		 199.65M 188.02M 188.29M 187.75M 188.41M 226.44M 245.50M 77.98M 77.54M 82.16M 83.94M
Weighted Average Basic & Diluted Shares Outstanding		 200.30M 187.50M 187.50M 187M 187.23M 230.56M 236.95M 231.83M 241.36M 80.92M 83.40M
Cash Dividends to Common per Share		 $1.92 $2.44 $2.00 $2.00 $2.00 $1.40 $1.29 - $2.10 $1.42 $1.48

Quarterly Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -16 12 111 34 114 -168 146 14 -22 6.50 -65
Consolidated Net Income / (Loss)		 2.17 31 129 57 136 -147 167 35 -0.58 28 -44
Net Income / (Loss) Continuing Operations		 2.17 31 129 57 136 -147 167 35 -0.58 28 -44
Total Pre-Tax Income 		2.25 31 129 57 136 -147 169 36 -0.33 28 -46
Total Revenue		 26 37 153 81 159 -130 207 67 41 72 11
Net Interest Income / (Expense)		 63 65 65 67 66 66 69 66 65 66 75
Total Interest Income		 196 191 187 187 195 192 191 201 209 220 219
Investment Securities Interest Income		 196 191 187 187 195 192 191 201 209 220 219
Total Interest Expense		 132 127 121 119 129 127 121 135 144 154 144
Long-Term Debt Interest Expense		 132 127 121 119 129 127 121 135 144 154 144
Total Non-Interest Income		 -37 -28 88 14 93 -196 137 1.38 -24 5.83 -64
Net Realized & Unrealized Capital Gains on Investments		 -37 -28 88 14 93 -198 128 -7.43 -33 -3.31 -73
Investment Banking Income		 - - 0.00 0.00 0.00 - 8.94 8.81 8.51 9.13 7.17
Other Non-Interest Income		 - - - - 0.00 - 0.00 - 0.50 - 2.31
Provision for Credit Losses		 3.22 2.33 1.35 3.68 0.36 4.45 3.39 4.41 2.59 5.32 2.82
Total Non-Interest Expense		 21 3.64 23 21 22 12 34 27 39 39 54
Salaries and Employee Benefits		 7.12 5.28 9.21 7.01 7.20 18 13 12 14 18 27
Other Operating Expenses		 14 -1.64 13 14 15 -6.15 20 15 24 16 18
Depreciation Expense		 - - 0.00 0.00 0.00 - 0.95 0.95 0.95 4.34 9.65
Income Tax Expense		 0.08 0.00 0.01 0.03 0.02 -0.01 1.76 0.41 0.25 -0.15 -2.06
Preferred Stock Dividends Declared		 18 18 18 23 23 22 21 21 21 22 21
Basic Earnings per Share		 ($0.22) $0.16 $1.37 $0.42 $1.41 ($2.08) $1.79 $0.17 ($0.27) $0.08 ($0.78)
Weighted Average Basic Shares Outstanding		 75.58M 76.69M 81.24M 81.33M 80.81M 80.98M 81.35M 81.41M 81.51M 82.18M 83.66M
Diluted Earnings per Share		 ($0.22) $0.16 $1.36 $0.41 $1.39 ($2.08) $1.77 $0.17 ($0.27) $0.08 ($0.78)
Weighted Average Diluted Shares Outstanding		 75.58M 77.54M 81.72M 82.28M 81.86M 82.16M 82.39M 82.60M 81.51M 83.94M 83.66M
Weighted Average Basic & Diluted Shares Outstanding		 226.76M 241.36M 241.42M 80.53M 80.88M 80.92M 80.97M 81.07M 83.15M 83.40M 83.65M
Cash Dividends to Common per Share		 $0.54 $0.56 - $0.35 $0.37 $0.64 $0.37 $0.37 $0.37 $0.65 $0.45

Annual Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -51 64 -114 -16 62 159 117 -121 -43 -138 200
Net Cash From Operating Activities		 396 553 487 298 65 258 519 326 213 206 -249
Net Cash From Continuing Operating Activities		 396 553 487 298 65 258 519 326 213 206 -249
Net Income / (Loss) Continuing Operations		 250 552 525 412 414 89 670 -513 126 176 230
Consolidated Net Income / (Loss)		 250 552 525 412 414 89 670 -513 126 176 230
Provision For Loan Losses		 - - - 0.00 0.00 0.18 0.03 7.04 11 9.87 16
Depreciation Expense		 - - - - - - - 0.00 0.00 0.32 7.18
Amortization Expense		 21 -1.58 -18 16 29 63 79 61 48 19 -6.10
Non-Cash Adjustments to Reconcile Net Income		 76 -61 -61 103 -317 -198 -193 822 -13 17 -438
Changes in Operating Assets and Liabilities, net		 49 63 42 -233 -61 304 -38 -51 40 -16 -58
Net Cash From Investing Activities		 2,038 -1,271 -4,331 -6,026 1,237 8,330 2,548 510 552 178 -1,657
Net Cash From Continuing Investing Activities		 2,038 -1,271 -4,331 -6,026 1,237 8,330 2,548 510 552 178 -1,657
Purchase of Investment Securities		 -7,833 -6,141 -7,860 -9,722 -7,670 -3,025 -3,080 -2,148 -1,266 -1,852 -4,889
Sale and/or Maturity of Investments		 9,868 4,871 3,529 3,696 8,906 11,355 5,628 2,658 1,818 2,031 3,232
Net Cash From Financing Activities		 -2,485 781 3,730 5,712 -1,240 -8,429 -2,951 -957 -808 -522 2,106
Net Cash From Continuing Financing Activities		 -2,485 781 3,730 5,712 -1,240 -8,429 -2,951 -957 -808 -522 2,106
Issuance of Debt		 1,483 4,797 5,152 1,770 1,487 3,404 5,522 1,123 2,186 474 1,127
Issuance of Common Equity		 - - - - - - 0.00 0.00 74 0.00 0.00
Repayment of Debt		 -2,321 -1,863 -2,975 -2,657 -1,870 -2,553 -6,462 -1,847 -1,767 -1,171 -1,543
Repurchase of Common Equity		 -250 0.00 0.00 -15 0.00 -22 -1.83 -49 -33 0.00 0.00
Payment of Dividends		 -381 -454 -412 -418 -447 -396 -372 -362 -251 -223 -209
Other Financing Activities, Net		 -1,016 -1,838 1,650 6,781 -604 -8,862 -1,636 178 -1,017 398 2,732
Cash Interest Paid		 237 335 512 644 835 578 339 323 470 479 535
Cash Interest Received		 881 917 1,092 1,279 1,427 1,168 1,020 842 774 761 799
Cash Income Taxes Paid		 - - - - 0.19 0.16 4.41 -0.25 0.10 0.05 3.53

Quarterly Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -62 83 -53 -6.65 -65 -13 169 -3.13 241 -207 199
Net Cash From Operating Activities		 45 31 57 69 41 38 49 -7.43 -137 -153 243
Net Cash From Continuing Operating Activities		 45 31 57 69 41 38 49 -7.43 -137 -153 243
Net Income / (Loss) Continuing Operations		 2.17 31 129 57 136 -147 167 35 -0.58 28 -44
Consolidated Net Income / (Loss)		 2.17 31 129 57 136 -147 167 35 -0.58 28 -44
Provision For Loan Losses		 3.22 2.33 1.35 3.69 0.36 4.48 3.39 4.41 2.59 5.32 2.82
Depreciation Expense		 - - 0.00 - - - 0.95 0.95 0.95 4.33 9.65
Amortization Expense		 14 3.95 9.70 13 -1.96 -2.42 -0.03 7.93 -6.37 -7.62 -4.79
Non-Cash Adjustments to Reconcile Net Income		 44 19 -83 -4.44 -88 192 -120 -2.97 43 -359 297
Changes in Operating Assets and Liabilities, net		 -19 -25 -0.51 -0.25 -5.74 -9.58 -2.76 -53 -177 176 -17
Net Cash From Investing Activities		 368 377 248 -114 -646 690 -175 -1,203 58 -337 356
Net Cash From Continuing Investing Activities		 368 377 248 -114 -646 690 -175 -1,203 58 -337 356
Purchase of Investment Securities		 -36 -0.08 -111 -461 -1,033 -247 -553 -1,805 -1,436 -1,094 -1,301
Sale and/or Maturity of Investments		 404 377 360 347 387 937 378 602 1,494 757 1,657
Net Cash From Financing Activities		 -475 -325 -358 38 540 -741 296 1,207 321 283 -400
Net Cash From Continuing Financing Activities		 -475 -325 -358 38 540 -741 296 1,207 321 283 -400
Issuance of Debt		 - 139 0.00 62 412 -0.00 780 - 347 - 0.00
Repayment of Debt		 -324 -305 -273 -295 -307 -296 -597 -307 -287 -353 -1,304
Payment of Dividends		 -62 -43 -45 -46 -80 -52 -52 -52 -51 -54 -53
Other Financing Activities, Net		 -81 -190 -40 316 515 -393 164 1,565 312 690 957
Cash Interest Paid		 125 119 120 114 124 122 122 128 142 143 146
Cash Interest Received		 199 186 188 209 182 182 185 214 200 200 212
Cash Income Taxes Paid		 - - - - - - 0.00 - - - 3.53

Annual Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 15,345 16,685 21,222 27,709 27,119 17,523 15,407 13,402 12,929 13,116 15,809
Cash and Due from Banks		 114 178 64 47 110 269 386 265 222 84 279
Trading Account Securities		 11,299 16,261 7,265 2,524 3.61 1,831 0.00 12,942 102 12,780 14,110
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans Held for Sale		 - - 13,678 12,573 14,293 13,112 12,262 - 11,397 0.00 896
Other Assets		 3,932 246 215 12,565 12,712 2,311 2,760 196 1,208 252 524
Total Liabilities & Shareholders' Equity		 15,345 16,685 21,222 27,709 27,119 17,523 15,407 13,402 12,929 13,116 15,809
Total Liabilities		 12,398 13,561 17,587 24,005 23,165 13,744 11,671 10,735 10,370 10,590 13,236
Short-Term Debt		 7,449 5,603 7,250 14,030 13,428 4,637 3,262 3,435 2,432 2,824 6,031
Accrued Interest Payable		 37 49 62 110 64 41 20 31 38 41 43
Other Short-Term Payables		 - 97 - - - - - 65 - 34 35
Long-Term Debt		 4,250 7,275 9,594 8,615 8,313 8,877 7,814 7,179 7,677 7,190 7,039
Other Long-Term Liabilities		 662 537 680 1,249 1,361 189 575 26 223 500 87
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,946 3,124 3,635 3,704 3,953 3,779 3,736 2,667 2,559 2,526 2,573
Total Preferred & Common Equity		 2,946 3,124 3,635 3,704 3,953 3,779 3,736 2,667 2,559 2,526 2,573
Preferred Stock		 0.00 0.06 0.19 0.29 0.37 0.37 0.37 0.37 0.37 0.37 0.37
Total Common Equity		 2,946 3,123 3,635 3,704 3,953 3,779 3,736 2,666 2,559 2,526 2,572
Common Stock		 3,368 3,511 3,829 4,074 4,278 4,540 4,361 4,321 4,371 4,391 4,430
Retained Earnings		 -1,196 -1,105 -991 -997 -1,033 -1,319 -1,031 -1,884 -1,998 -2,025 -2,004
Accumulated Other Comprehensive Income / (Loss)		 774 718 797 627 708 558 405 229 186 159 146

Quarterly Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 13,669 14,204 13,510 12,887 12,547 13,132 13,702 13,205 14,863 15,115 15,979
Cash and Due from Banks		 86 232 201 139 169 162 97 253 250 491 476
Trading Account Securities		 13,369 278 143 128 66 12,793 13,425 656 14,327 2,927 14,248
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans Held for Sale		 - 12,382 11,930 11,427 11,075 - - 10,984 - 10,318 701
Other Assets		 200 1,311 1,237 1,194 1,237 176 180 1,312 286 1,380 555
Total Liabilities & Shareholders' Equity		 13,669 14,204 13,510 12,887 12,547 13,132 13,702 13,205 14,863 15,115 15,979
Total Liabilities		 11,016 11,554 10,930 10,393 9,901 10,491 10,965 10,561 12,239 12,544 13,516
Short-Term Debt		 2,821 3,195 2,687 2,604 2,385 2,699 3,229 2,994 4,563 4,877 6,987
Accrued Interest Payable		 26 31 37 36 35 39 40 38 41 38 37
Other Short-Term Payables		 64 - - - - 61 34 - 35 - 41
Long-Term Debt		 7,434 7,585 8,118 7,675 7,410 7,214 7,521 7,403 7,174 7,342 5,747
Other Long-Term Liabilities		 671 743 88 79 71 477 142 126 426 288 704
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,654 2,649 2,579 2,494 2,646 2,641 2,737 2,644 2,625 2,571 2,464
Total Preferred & Common Equity		 2,654 2,649 2,579 2,494 2,646 2,641 2,737 2,644 2,625 2,571 2,464
Preferred Stock		 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37
Total Common Equity		 2,653 2,649 2,579 2,494 2,645 2,641 2,737 2,644 2,624 2,571 2,463
Common Stock		 4,317 4,323 4,292 4,294 4,374 4,376 4,380 4,395 4,398 4,400 4,433
Retained Earnings		 -1,908 -1,899 -1,923 -1,981 -1,914 -1,910 -1,826 -1,909 -1,926 -1,979 -2,107
Accumulated Other Comprehensive Income / (Loss)		 244 225 211 181 185 174 184 158 152 149 138

Annual Metrics And Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.69 $1.12 $1.76
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 76.69M 80.98M 82.18M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.69 $1.10 $1.72
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 77.54M 82.16M 83.94M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 80.45M 80.92M 83.40M
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 83,402,526.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 83,402,526.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.53
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 116.20% -73.92% 67.69% 16.20% 507.03% -455.94% 34.55% -16.94% -74.37% - -94.68%
EBITDA Growth		 109.50% -64.12% 104.71% 26.11% 723.66% -531.74% 22.14% -36.16% -104.28% - -124.19%
EBIT Growth		 101.21% -69.68% 125.68% 57.27% 5,979.06% -579.66% 30.58% -36.75% -100.24% - -127.20%
NOPAT Growth		 101.67% -68.58% 125.66% 57.30% 6,188.43% -435.79% 29.23% -37.44% -100.17% - -119.24%
Net Income Growth		 101.17% -68.58% 125.66% 57.30% 6,188.43% -579.68% 29.23% -37.44% -100.43% - -126.25%
EPS Growth		 101.17% -68.58% 125.66% 78.26% 731.82% -1,400.00% 30.15% -58.54% -119.42% - -144.07%
Operating Cash Flow Growth		 9.97% 18.51% 88.15% -35.37% -7.31% 21.14% -14.80% -110.76% -431.94% - 398.61%
Free Cash Flow Firm Growth		 -94.76% -60.48% -24.53% 65.02% -518.10% -96.21% -138.79% -299.86% -125.52% - -404.18%
Invested Capital Growth		 -1.05% -4.62% -7.37% -6.20% 5.59% -1.00% 4.84% 14.40% 9.66% - 16.54%
Revenue Q/Q Growth		 -62.42% 39.14% 320.33% -47.13% 96.33% -181.58% 258.90% -67.37% -39.43% - -84.75%
EBITDA Q/Q Growth		 -70.61% 111.23% 303.38% -49.64% 91.97% -210.72% 214.12% -73.68% -112.86% - -265.16%
EBIT Q/Q Growth		 -93.77% 1,260.62% 323.83% -56.21% 140.72% -207.36% 215.38% -78.79% -100.92% - -263.13%
NOPAT Q/Q Growth		 -93.98% 1,307.56% 323.83% -56.23% 140.82% -175.16% 263.12% -78.81% -100.65% - -213.59%
Net Income Q/Q Growth		 -93.98% 1,307.56% 323.83% -56.23% 140.82% -207.37% 214.19% -78.81% -101.64% - -254.98%
EPS Q/Q Growth		 -93.98% 1,307.56% 323.83% -8.89% 239.02% -249.64% 185.10% -90.40% -258.82% - -1,075.00%
Operating Cash Flow Q/Q Growth		 -58.17% -29.89% 82.83% 20.53% -40.00% -8.37% 28.58% -115.22% -1,750.55% - 259.27%
Free Cash Flow Firm Q/Q Growth		 -74.29% 365.69% 73.96% -20.76% -165.13% 104.23% -1,878.29% -308.26% 26.50% - 28.79%
Invested Capital Q/Q Growth		 -4.57% -0.82% -1.80% 0.92% 7.43% -7.02% 3.99% 10.13% 2.98% - -2.85%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 62.24% 94.48% 90.67% 86.36% 84.45% 0.00% 82.31% 66.39% -14.09% - -374.33%
EBIT Margin		 8.56% 83.66% 84.36% 69.88% 85.67% 0.00% 81.87% 53.21% -0.81% - -418.53%
Profit (Net Income) Margin		 8.27% 83.65% 84.35% 69.84% 85.66% 0.00% 81.01% 52.61% -1.42% - -399.73%
Tax Burden Percent		 96.66% 99.99% 99.99% 99.95% 99.99% 100.00% 98.96% 98.86% 176.29% - 95.51%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Effective Tax Rate		 3.34% 0.01% 0.01% 0.05% 0.01% 0.00% 1.04% 1.14% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 0.21% 1.44% 1.87% 1.69% 2.92% 0.00% 2.02% 1.19% -0.01% - -3.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.21% 1.44% 1.87% 1.69% 2.92% 0.00% 2.02% 1.19% -0.01% - -4.07%
Return on Net Nonoperating Assets (RNNOA)		 0.84% 5.73% 7.25% 6.72% 11.74% 0.00% 7.69% 4.87% -0.05% - -18.43%
Return on Equity (ROE)		 1.05% 7.17% 9.11% 8.42% 14.66% 0.00% 9.71% 6.06% -0.05% - -22.39%
Cash Return on Invested Capital (CROIC)		 2.56% 5.70% 9.19% 8.09% -2.75% 2.40% -3.04% -12.00% -8.82% - -15.14%
Operating Return on Assets (OROA)		 0.21% 1.42% 1.80% 1.65% 2.88% 0.00% 2.02% 1.15% -0.01% - -5.48%
Return on Assets (ROA)		 0.20% 1.42% 1.80% 1.65% 2.88% 0.00% 1.99% 1.14% -0.02% - -5.24%
Return on Common Equity (ROCE)		 1.05% 7.17% 9.11% 8.41% 14.66% 0.00% 9.71% 6.06% -0.05% - -22.39%
Return on Equity Simple (ROE_SIMPLE)		 7.73% 0.00% 7.49% 8.29% 12.90% 0.00% 8.09% 7.34% 2.16% - 0.78%
Net Operating Profit after Tax (NOPAT)		 2.17 31 129 57 136 -103 167 35 -0.23 - -32
NOPAT Margin		 8.27% 83.65% 84.35% 69.84% 85.66% 0.00% 81.01% 52.61% -0.56% - -292.96%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.44% 0.00% 0.00% 0.00% - 0.10%
SG&A Expenses to Revenue		 27.15% 14.46% 6.00% 8.64% 4.52% 0.00% 6.34% 17.30% 33.70% - 243.11%
Operating Expenses to Revenue		 79.19% 9.96% 14.77% 25.58% 14.10% 0.00% 16.49% 40.24% 94.47% - 492.82%
Earnings before Interest and Taxes (EBIT)		 2.25 31 129 57 136 -147 169 36 -0.33 - -46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 16 34 139 70 135 -149 170 45 -5.75 - -41
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.45 0.40 0.37 0.39 0.47 0.45 0.39 0.43 0.42 - 0.42
Price to Tangible Book Value (P/TBV)		 0.45 0.40 0.37 0.39 0.47 0.45 0.39 0.43 0.42 - 0.42
Price to Revenue (P/Rev)		 3.45 4.56 3.41 3.27 2.85 4.29 3.28 3.70 5.80 - 5.47
Price to Earnings (P/E)		 9.45 19.51 7.84 7.32 4.71 12.53 8.29 10.66 0.00 - 0.00
Dividend Yield		 16.54% 15.54% 17.31% 12.11% 8.72% 10.14% 11.38% 10.67% 11.20% - 12.43%
Earnings Yield		 10.58% 5.13% 12.75% 13.67% 21.24% 7.98% 12.06% 9.38% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.88 0.86 0.85 0.86 0.88 0.88 0.86 0.88 0.87 - 0.88
Enterprise Value to Revenue (EV/Rev)		 34.57 48.68 37.06 34.28 26.65 41.92 35.28 41.59 69.28 - 69.59
Enterprise Value to EBITDA (EV/EBITDA)		 45.96 62.56 43.17 41.46 31.53 56.70 49.49 62.86 212.13 - 584.54
Enterprise Value to EBIT (EV/EBIT)		 54.83 86.44 53.46 49.24 33.77 62.82 51.84 64.71 220.42 - 750.10
Enterprise Value to NOPAT (EV/NOPAT)		 58.44 86.51 53.49 49.27 33.78 62.84 52.28 65.45 229.97 - 689.68
Enterprise Value to Operating Cash Flow (EV/OCF)		 54.06 51.15 44.15 53.29 59.92 53.79 56.71 104.45 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 34.26 14.76 8.92 10.28 0.00 36.51 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 4.12 3.95 3.70 3.75 3.93 3.96 3.93 4.47 4.75 - 5.17
Long-Term Debt to Equity		 3.08 3.00 2.80 2.73 2.75 2.85 2.80 2.73 2.86 - 2.33
Financial Leverage		 3.99 3.97 3.89 3.97 4.02 3.96 3.82 4.11 4.33 - 4.53
Leverage Ratio		 5.16 5.04 5.05 5.10 5.08 5.12 4.87 5.32 5.43 - 5.71
Compound Leverage Factor		 5.16 5.04 5.05 5.10 5.08 5.12 4.87 5.32 5.43 - 5.71
Debt to Total Capital		 80.47% 79.80% 78.73% 78.96% 79.70% 79.86% 79.73% 81.73% 82.61% - 83.79%
Short-Term Debt to Total Capital		 20.39% 19.20% 19.17% 21.50% 23.94% 22.52% 22.96% 31.77% 32.98% - 45.97%
Long-Term Debt to Total Capital		 60.08% 60.60% 59.56% 57.46% 55.76% 57.34% 56.77% 49.95% 49.64% - 37.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 19.53% 20.20% 21.26% 21.04% 20.29% 20.14% 20.27% 18.27% 17.38% - 16.21%
Debt to EBITDA		 41.94 57.97 39.89 38.12 28.42 51.32 46.02 58.51 202.50 - 559.46
Net Debt to EBITDA		 41.38 56.70 39.20 37.49 28.16 50.89 44.90 57.26 194.36 - 538.54
Long-Term Debt to EBITDA		 31.32 44.03 30.18 27.74 19.88 36.85 32.76 35.76 121.68 - 252.49
Debt to NOPAT		 53.32 80.16 49.42 45.30 30.44 56.88 48.61 60.91 219.54 - 660.09
Net Debt to NOPAT		 52.60 78.41 48.57 44.56 30.17 56.40 47.42 59.61 210.71 - 635.40
Long-Term Debt to NOPAT		 39.81 60.88 37.39 32.96 21.30 40.84 34.61 37.23 131.91 - 297.91
Noncontrolling Interest Sharing Ratio		 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.01% 0.01% 0.01% - 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 138 643 1,119 887 -578 24 -434 -1,773 -1,303 - -2,189
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Free Cash Flow to Firm to Interest Expense		 1.05 5.08 9.22 7.43 -4.48 0.19 -3.58 -13.10 -9.04 - -15.17
Operating Cash Flow to Interest Expense		 0.34 0.25 0.47 0.58 0.32 0.30 0.40 -0.05 -0.95 - 1.69
Operating Cash Flow Less CapEx to Interest Expense		 0.34 0.25 0.47 0.58 0.32 0.30 0.40 -0.05 -0.95 - 1.69
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.01 - 0.01
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12,773 12,668 12,440 12,554 13,487 12,541 13,041 14,362 14,790 - 15,198
Invested Capital Turnover		 0.03 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.01 - 0.01
Increase / (Decrease) in Invested Capital		 -136 -613 -990 -830 714 -127 601 1,808 1,303 - 2,157
Enterprise Value (EV)		 11,264 10,909 10,602 10,781 11,928 11,063 11,182 12,611 12,799 - 13,305
Market Capitalization		 1,124 1,021 976 1,030 1,275 1,132 1,038 1,123 1,072 - 1,047
Book Value per Share		 $11.00 $11.28 $10.96 $10.94 $33.99 $31.23 $32.67 $32.41 $31.71 - $29.54
Tangible Book Value per Share		 $11.00 $11.28 $10.96 $10.94 $33.99 $31.23 $32.67 $32.41 $31.71 - $29.54
Total Capital		 12,773 12,668 12,440 12,554 13,487 12,541 13,041 14,362 14,790 - 15,198
Total Debt		 10,278 10,109 9,794 9,913 10,750 10,015 10,397 11,738 12,219 - 12,734
Total Long-Term Debt		 7,675 7,677 7,410 7,214 7,521 7,190 7,403 7,174 7,342 - 5,747
Net Debt		 10,140 9,887 9,625 9,751 10,652 9,931 10,144 11,487 11,727 - 12,258
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 44 0.00 0.00 0.35 - 12
Net Nonoperating Obligations (NNO)		 10,278 10,109 9,794 9,913 10,750 10,015 10,397 11,738 12,219 - 12,734
Total Depreciation and Amortization (D&A)		 14 3.95 9.70 13 -1.96 -2.42 0.92 8.88 -5.42 - 4.86
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.21) $0.48 $1.38 $0.42 $1.41 ($2.08) $1.79 $0.17 ($0.27) $0.08 ($0.78)
Adjusted Weighted Average Basic Shares Outstanding		 75.58M 25.56M 81.24M 81.33M 80.81M 80.98M 81.35M 81.41M 81.51M 82.18M 83.66M
Adjusted Diluted Earnings per Share		 ($0.21) $0.48 $1.35 $0.41 $1.39 ($2.08) $1.77 $0.17 ($0.27) $0.08 ($0.78)
Adjusted Weighted Average Diluted Shares Outstanding		 75.58M 25.85M 81.72M 82.28M 81.86M 82.16M 82.39M 82.60M 81.51M 83.94M 83.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.48 $0.00 $0.00 $0.00 ($2.08) $0.00 $0.00 $0.00 $0.08 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 75.59M 80.45M 80.47M 80.53M 80.88M 80.92M 80.97M 81.07M 83.15M 83.40M 83.65M
Normalized Net Operating Profit after Tax (NOPAT)		 2.17 31 129 57 136 -103 167 35 -0.23 - -32
Normalized NOPAT Margin		 8.27% 83.65% 84.35% 69.84% 85.66% 0.00% 81.01% 52.61% -0.56% - -292.96%
Pre Tax Income Margin		 8.56% 83.66% 84.36% 69.88% 85.67% 0.00% 81.86% 53.21% -0.81% - -418.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.02 0.24 1.07 0.47 1.06 -1.16 1.39 0.27 0.00 - -0.32
NOPAT to Interest Expense		 0.02 0.24 1.07 0.47 1.06 -0.81 1.38 0.26 0.00 - -0.22
EBIT Less CapEx to Interest Expense		 0.02 0.24 1.07 0.47 1.06 -1.16 1.39 0.27 0.00 - -0.32
NOPAT Less CapEx to Interest Expense		 0.02 0.24 1.07 0.47 1.06 -0.81 1.38 0.26 0.00 - -0.22
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 145.15% 198.67% 112.27% 89.62% 60.64% 126.80% 107.50% 122.43% 371.72% - 1,089.80%
Augmented Payout Ratio		 162.32% 224.92% 112.27% 92.77% 60.64% 126.80% 107.50% 122.43% 371.72% - 1,089.80%

Financials Breakdown Chart

Key Financial Trends

Chimera Investment (NYSE: CIM) has shown a sharp recovery in profitability and cash generation after a volatile 2024, but the latest quarter still highlights a highly leveraged, interest-rate-sensitive business model. For REIT-style mortgage investors like Chimera, the key question is not just earnings, but whether net interest spreads, asset values, and financing costs are moving in the right direction. Based on the last four years of quarterly statements, the trend is mixed: 2025 ended much stronger than 2024, but Q1 2026 slipped back into a loss.

What stands out most: Chimera’s results appear to swing heavily with gains and losses on investments, while recurring operating profitability remains under pressure from high interest expense and large preferred dividends. The balance sheet is still sizable, with assets around $15.98 billion in Q1 2026, but liabilities remain elevated at $13.52 billion, leaving limited common equity cushion.

  • Q1 2026 operating cash flow was strong at $243.3 million, up from a negative $152.8 million in Q4 2025 and a negative $137.5 million in Q3 2025.
  • The company generated positive investing cash flow in Q1 2026 of $355.7 million, helped by $1.66 billion in sales and maturities of investments versus $1.30 billion in purchases.
  • Net change in cash and equivalents was positive in Q1 2026 at $198.6 million, improving the liquidity profile.
  • Q4 2025 marked a clear rebound in earnings, with consolidated net income of $28.3 million and EPS of $0.08 after a weak Q3 2025.
  • Full-year momentum improved across 2025, with Q1 2025 showing especially strong results: $167.3 million in net income and $1.79 EPS, though that quarter was later restated.
  • Interest income remained relatively steady in the latest quarter at $219.3 million, only slightly below Q4 2025 and above prior-year levels.
  • Net interest income improved to $75.0 million in Q1 2026 from $66.2 million in Q4 2025, suggesting some spread improvement.
  • The portfolio remains concentrated in trading account securities and loans held for sale, which fits Chimera’s model but also adds mark-to-market volatility.
  • Q1 2026 still produced a consolidated net loss of $43.9 million, or -$0.78 per share.
  • Non-interest income was deeply negative in Q1 2026 at -$64.0 million, driven by -$73.5 million in net realized and unrealized capital losses on investments.
  • Total revenue in Q1 2026 was only $11.0 million, underscoring how dependent results are on investment marks and other non-core items.
  • Interest expense remains heavy at $144.3 million in Q1 2026, leaving relatively thin net interest spread income.
  • Preferred stock dividends were $21.1 million in Q1 2026, which further reduces earnings available to common shareholders.
  • Debt remains substantial, with $12.73 billion of short-term and long-term debt combined on the Q1 2026 balance sheet.
  • Common equity of $2.46 billion is modest relative to total assets and liabilities, highlighting leverage risk if asset values weaken.

Longer-term trend: 2024 was rough, with large losses in several quarters, especially when investment marks turned sharply negative. The story improved in 2025, as Chimera posted multiple profitable quarters and stronger cash generation. However, the latest quarter shows that earnings can still swing back quickly. That makes CIM a stock where distributions, leverage, and spread performance matter more than simple revenue growth.

Bottom line: Chimera appears to be in better shape than during its 2024 slump, but the business is still volatile. The improving cash flow and late-2025 earnings recovery are encouraging, yet the Q1 2026 loss and large debt load suggest investors should expect uneven results and significant sensitivity to rates, credit conditions, and portfolio marks.

06/16/26 09:29 PM ETAI Generated. May Contain Errors.

Chimera Investment Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Chimera Investment's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Chimera Investment's net income appears to be on a downward trend, with a most recent value of $230.50 million in 2025, falling from $250.35 million in 2015. The previous period was $176.07 million in 2024. See where experts think Chimera Investment is headed by visiting Chimera Investment's forecast page.

Over the last 10 years, Chimera Investment's total revenue changed from $343.75 million in 2015 to $386.72 million in 2025, a change of 12.5%.

Chimera Investment's total liabilities were at $13.24 billion at the end of 2025, a 25.0% increase from 2024, and a 6.8% increase since 2015.

In the past 10 years, Chimera Investment's cash and equivalents has ranged from $47.49 million in 2018 to $385.74 million in 2021, and is currently $278.58 million as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:CIM last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The pre-flight check for options traders
Pilots never skip their pre-flight checklist - and neither should options traders. The Smart Trade Options Che...
Profits Run | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A 3M Oz. Historical Gold Resource And A Market That Hasn't Caught Up
One Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...
Wall Street Logic | Sponsoredtc pixel
BUY THIS: Claim a backdoor stake in SpaceX
There may be a way to claim pre-IPO exposure to SpaceX before it ever hits public markets - using a simple tra...
Chaikin Analytics | Sponsoredtc pixel